Overview Clinical Study to Evaluate Efficacy and Safety of DA-1229 in Patients With CAVD Status: Active, not recruiting Trial end date: 2022-12-31 Target enrollment: Participant gender: Summary This study will evaluate the efficacy and safety of DA-1229 in patients with calcific aortic valve disease. Phase: Phase 2 Details Lead Sponsor: Dong-A ST Co., Ltd.